The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome - Wikidata - wikimedia - TriplyDB

The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome

The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome

http://www.wikidata.org/entity/Q28568698

about

Acid-sensing ion channel 1a contributes to the effect of extracellular acidosis on NLRP1 inflammasome activation in cortical neurons Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects Caspase-1 modulates incisional sensitization and inflammation Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.Effects of a skin neuropeptide (substance p) on cutaneous microflora.Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytes Injury Location and Mechanism for Complex Regional Pain Syndrome: A Nationwide Population-Based Case-Control Study in Taiwan.In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain.Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis.Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.Roles of Gr-1+ leukocytes in postincisional nociceptive sensitization and inflammation miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression.Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress.Differential Efficacy of Ketamine in the Acute versus Chronic Stages of Complex Regional Pain Syndrome in Mice Mast Cell-Mediated Mechanisms of Nociception.AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome.Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling.Acute and chronic phases of complex regional pain syndrome in mice are accompanied by distinct transcriptional changes in the spinal cord.Glia and pain: is chronic pain a gliopathy?NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10.Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain.Rethinking the psychogenic model of complex regional pain syndrome: somatoform disorders and complex regional pain syndrome Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons.The inflammasome as a target for pain therapy.Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1β maturation.Passive transfer autoimmunity in a mouse model of complex regional pain syndrome.Immunomodulation in perioperative medicine.The Rodent Tibia Fracture Model: A Critical Review and Comparison with the Complex Regional Pain Syndrome Literature.Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.Hypoxia inducible factor-1α inhibition produced anti-allodynia effect and suppressed inflammatory cytokine production in early stage of mouse complex regional pain syndrome model.The inflammasome in fibromyalgia and CRPS: a microglial hypothesis?Autoinflammatory and autoimmune contributions to complex regional pain syndrome

P2860

78b6ee2814e729e293186db289dba40e61958d4c

P248

Q27303473-96C36050-4150-4538-80B4-FC2E1DBA3E4C Q33852646-AD99725F-B544-4F7E-AFD3-EADDD3A40DFB Q34154905-D0352A52-4400-460B-8B67-186BE257AF51 Q34550052-7B0F01F0-924F-4D8D-B28B-FA3D58C54493 Q34614091-CD940945-1220-410D-816A-1DC7FB0BAD66 Q35046639-A10841C1-A420-46E7-8DF0-5A05E4C37349 Q35068859-A1A4D170-4C99-4828-9219-C230B5317963 Q35163672-A6DC95D3-9550-40FD-9440-FE87F515D065 Q35735946-1AF67431-974E-4B8D-8E07-3BD6EA221E1F Q35846222-597CBD13-E5FF-4740-A971-CF8B34C75134 Q35850819-45CDCC65-6DF0-467B-A42B-37706849C117 Q36188477-CF75D1D9-CC49-461D-ACD8-54CEB697CAB8 Q36197696-A01D4193-2122-4DDC-8D6C-BD40D7D4D727 Q36324486-3CE4177C-D6CB-4E39-987A-40C1559C592F Q36372728-A7D656FD-DC8D-4FF5-9D46-FE1085A677BD Q36404141-5E20B1B2-5DB9-468C-A00A-87D7C71E20F8 Q36549279-B644553D-F96D-4701-AB31-A2B85E772F53 Q36868585-36E98774-8BE4-4A2F-A8D7-BF2018769B07 Q37020591-75FC1D66-BE5C-4BCA-ADEA-E6D53C20505E Q37067714-40EFF3FF-1878-4041-899A-F7220D096EB4 Q37116137-E6599850-6C02-4FBA-9CA0-6F1F818D83B5 Q37381399-E482A160-ED94-44B3-96ED-E0B2D0B80A90 Q37602813-366C878A-5C33-450F-BC0B-EF0D56BC948A Q37765512-B471CC9E-26C2-4811-9633-6A9991C9A97C Q38162212-BFF9E471-C5E2-434B-AE38-8E3D8A71C0BA Q38341513-3D2ECD89-09BE-4062-8F87-E56DAAEAF676 Q39036848-70BFC2FA-A256-43AF-B2C4-090833589BBA Q39061689-D9C1E32D-08FA-4F5E-9FBB-0711342671BB Q42382574-830A5404-4F78-432A-A1FD-F3B83AC47859 Q42407070-2DD390EE-398C-4FE6-80A3-4381A05F6954 Q47254079-49798DD0-810F-44B8-98E2-436D553B3B55 Q48283740-92DA42D3-B405-40A0-A788-C81AEF0AC24B Q52312548-18005716-9CD3-43B5-AC96-FEFA676F60E4 Q52692785-21668E7D-53FF-488B-9F8B-F1478FF7DE65 Q53352139-1B34D954-6995-45F7-8701-CA6D90B5B133 Q53512808-D16353AA-B040-4B85-95DF-E5B583E4F518 Q58733893-A0212AC2-B0D6-4184-A451-2B81B9E7A11F

P2860

The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome

http://www.wikidata.org/entity/Q28568698

description

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2009

@ast

im Oktober 2009 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2009/12/15)

@sk

vědecký článek publikovaný v roce 2009

@cs

wetenschappelijk artikel (gepubliceerd op 2009/12/15)

@nl

наукова стаття, опублікована в жовтні 2009

@uk

مقالة علمية (نشرت في 15-12-2009)

@ar

name

The NALP1 inflammasome control ...... complex regional pain syndrome

@ast

The NALP1 inflammasome control ...... complex regional pain syndrome

@en

The NALP1 inflammasome control ...... complex regional pain syndrome

@nl

type

label

The NALP1 inflammasome control ...... complex regional pain syndrome

@ast

The NALP1 inflammasome control ...... complex regional pain syndrome

@en

The NALP1 inflammasome control ...... complex regional pain syndrome

@nl

prefLabel

The NALP1 inflammasome control ...... complex regional pain syndrome

@ast

The NALP1 inflammasome control ...... complex regional pain syndrome

@en

The NALP1 inflammasome control ...... complex regional pain syndrome

@nl

P1433

Q28568698-50BEBEB0-3546-4ED8-811A-B97B4EA09CFB

P1476

Q28568698-C3923C15-E01D-4760-AC6E-C61455ACE588

P2093

Q28568698-6D38507F-BDE9-4FE7-A6DE-378541819828

Q28568698-79E07BF9-0BFA-430E-B545-2F59D7AF5217

Q28568698-837400AD-F570-46E8-9DFC-0682723ED211

Q28568698-A3E085ED-C71D-4CFC-A400-682C9FE8C27E

Q28568698-ADFBE4BB-3124-49D2-9530-11389C7CF62F

Q28568698-B5857ED6-75B7-483A-8816-3FA14CDD6CD9

Q28568698-EEB598F2-F782-458C-A732-2D3A8D473CC6

P2860

Q28568698-07D934DA-A426-4F36-84E2-A0D738ED4378

Q28568698-0972E0C9-F554-4DC4-BFA6-8B6217BC0519

Q28568698-0DEC09C7-8A2D-42BD-A169-DB83ABD3A1CF

Q28568698-1AFC0303-F220-48EC-9116-177D65204B80

Q28568698-2893B33D-744A-46EC-957D-C8FCA9196295

Q28568698-31E0904B-134E-43D7-A7C3-F54EB3B335F6

Q28568698-3402CAD6-5280-490D-B27B-9C0D4A3D074B

Q28568698-35C428F6-0ED3-4863-B9B7-B0A51ACA387E

Q28568698-3AAEA77F-C2C7-4EF1-87FC-1AF4E62ADF54

Q28568698-3BD2D17A-F77E-43FB-B74B-AC052E429254

P304

Q28568698-3A8CA4F8-BC95-4BCC-9EDA-7B6CE410F33A

P31

Q28568698-265C50F6-7CB4-42A2-BA20-92F1BEE5EFD6

P3181

Q28568698-B0E1FE18-F015-4094-BF35-26325A9CF690

P356

Q28568698-D99C7E9F-CBC9-4EA9-9FA4-B71A3D60F8F7

P407

Q28568698-57F6A6C0-3AB2-4BBC-9B66-CEF65545D9FE

P433

Q28568698-4145FE9F-33CD-4051-ACD3-B26AE4A87F70

P478

Q28568698-C24CC6B9-C83B-482F-B047-B83B9D18E80B

P577

Q28568698-A9D3364E-B522-42D2-9808-F7C57E1FE49E

P5875

Q28568698-D0F70451-1453-4FE8-8411-1F54A3FE6B7F

P698

Q28568698-B953B0F8-410B-4D9B-9048-4B99053A9A79

P921

Q28568698-914D6D57-BFBF-4B2D-8A97-600F478B9913

P932

Q28568698-C766696E-2806-4026-B401-C5185B0111F6

P3181

P356

J.PAIN.2009.09.032

P1433

P1476

The NALP1 inflammasome control ...... complex regional pain syndrome

@en

P2093

Deyong Liang

http://www.w3.org/2001/XMLSchema#string

J David Clark

http://www.w3.org/2001/XMLSchema#string

Tian-Zhi Guo

http://www.w3.org/2001/XMLSchema#string

Tzuping Wei

http://www.w3.org/2001/XMLSchema#string

Wade S Kingery

http://www.w3.org/2001/XMLSchema#string

Wen-Wu Li

http://www.w3.org/2001/XMLSchema#string

Xiaoyou Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC

Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response

Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines

Gout-associated uric acid crystals activate the NALP3 inflammasome

A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes

Primer: inflammasomes and interleukin 1beta in inflammatory disorders

Cryopyrin activates the inflammasome in response to toxins and ATP

Regulation of peripheral inflammation by spinal p38 MAP kinase in rats

P304

277-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

232140

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.PAIN.2009.09.032

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38032843

http://www.w3.org/2001/XMLSchema#string

P698

19853379

http://www.w3.org/2001/XMLSchema#string

P921

P932

5515229

http://www.w3.org/2001/XMLSchema#string